As of November 2024, DexCom has a market cap of $26.62B. This makes DexCom the world's 688th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $45.01B | -6.03% |
2023 | $47.90B | 9.58% |
2022 | $43.71B | -15.64% |
2021 | $51.82B | 45.23% |
2020 | $35.68B | 69.02% |
2019 | $21.11B | 82.59% |
2018 | $11.56B | 108.75% |
2017 | $5.54B | -3.87% |
2016 | $5.76B | -27.11% |
2015 | $7.90B | 48.77% |
2014 | $5.31B | 55.46% |
2013 | $3.42B | 160.56% |
2012 | $1.31B | 45.97% |
2011 | $898.41M | -31.79% |
2010 | $1.32B | 69.14% |
2009 | $778.75M | 192.39% |
2008 | $266.34M | -68.74% |
2007 | $852.10M | -10.45% |
2006 | $951.49M | -33.91% |
2005 | $1.44B | -96.08% |
1970 | $36.70B | 0.00% |
1969 | $36.70B | - |